A Safety and Efficacy Study of One-time SAR402663 in Adults With Neovascular Age-related Macular Degeneration
Clinical trial NCT06660667 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06660667
- Sponsor
- Sanofi
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-21
- Primary completion
- 2027-05-18
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.